SRTA Strata Critical Medical, Inc.
Transportation Services · Nasdaq · SEC CIK 1779128 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY68.4%
TTM net income YoY-161.4%
TTM EPS YoY-160.0%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—
Margins
Gross margin21.6%
Operating margin-6.6%
Net margin-8.8%
FCF margin0.3%
EBITDA margin-3.2%
Returns
ROE-8.9%
ROA-7.5%
ROIC (approx.)-5.9%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets16.0%
Debt / equity0.00x
Current ratio2.77x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.43x
Accruals ratio-10.7%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $197.14M | $146.82M | $225.18M | $146.12M | $50.53M |
| Cost of revenue | $156.01M | $117.23M | $183.06M | $123.84M | $40.01M |
| Gross profit | $41.13M | $29.59M | $42.12M | $22.27M | $10.52M |
| SG&A expense | $60.88M | $50.86M | $95.17M | $62.51M | $30.14M |
| Operating income | -$22.35M | -$22.52M | -$68.12M | -$53.53M | -$24.09M |
| Pretax income | -$20.07M | -$16.16M | -$57.54M | -$28.03M | -$43.70M |
| Income tax | $0 | $0 | -$1.47M | -$772,000 | -$3.64M |
| Net income | $41.35M | -$27.31M | -$56.08M | -$27.26M | -$40.05M |
| EBITDA | -$14.17M | -$16.56M | -$61.01M | -$47.80M | -$23.26M |
| EPS (basic) | 0.50 | -0.35 | -0.76 | -0.38 | -0.93 |
| EPS (diluted) | 0.50 | -0.35 | -0.76 | -0.38 | -0.93 |
| Weighted avg. shares (diluted) | 82.09M | 77.50M | 73.52M | 71.24M | 42.88M |
| Banking | |||||
| Net interest income | — | $7.21M | $8.44M | $3.43M | $460,000 |
| Balance sheet | |||||
| Cash & equivalents | $31.23M | $19.65M | $29.02M | $44.42M | $6.95M |
| Short-term investments | $30.26M | $108.76M | $138.26M | $150.74M | $297.18M |
| Receivables | $39.96M | $19.82M | $21.00M | $10.88M | $3.77M |
| Current assets | $126.19M | $160.74M | $206.26M | $218.13M | $314.45M |
| PP&E, net | $36.44M | $28.46M | $2.90M | $2.04M | $1.96M |
| Goodwill | $88.21M | $15.54M | $13.33M | $39.45M | $13.27M |
| Intangibles | $47.50M | $7.96M | $20.52M | $46.37M | $12.64M |
| Total assets | $325.47M | $256.68M | $294.94M | $325.02M | $343.39M |
| Current liabilities | $19.79M | $22.73M | $35.49M | $26.61M | $9.53M |
| Long-term debt | — | — | — | $0 | — |
| Total debt | — | — | — | $0 | — |
| Total liabilities | $46.40M | $34.74M | $60.64M | $50.54M | $52.16M |
| Shareholders' equity | $279.07M | $221.94M | $234.30M | $274.49M | $291.23M |
| Net debt | — | — | — | -$44.42M | — |
| Cash flow statement | |||||
| Operating cash flow | -$48.91M | -$2.52M | -$32.35M | -$37.13M | -$15.62M |
| Capital expenditure | $9.60M | $30.86M | $2.11M | $730,000 | $297,000 |
| Free cash flow | -$58.51M | -$33.38M | -$34.46M | -$37.86M | -$15.91M |
| Investing cash flow | $69.75M | -$1.02M | $17.09M | $79.34M | -$321.34M |
| Financing cash flow | -$8.91M | -$5.76M | -$76,000 | -$1.08M | $332.26M |
| Depreciation & amortization | $8.19M | $5.96M | $7.11M | $5.72M | $830,000 |
| Stock-based compensation | $17.83M | $19.89M | $12.50M | $8.28M | $9.62M |
| Share buybacks | $0 | $244,000 | $0 | — | — |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.